• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. ATLAS GOLD PTA DILATATION CATHETER; PTA BALLOON DILATATION CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. ATLAS GOLD PTA DILATATION CATHETER; PTA BALLOON DILATATION CATHETER Back to Search Results
Model Number ATG80184
Medical Device Problem Codes Retraction Problem (1536); Detachment of Device or Device Component (2907)
Health Effect - Clinical Code Injury (2348)
Date of Event 05/23/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
As the lot number for the device was provided, a review of the device history records is currently being performed.The device has been returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.(expiry date: 01/2022).
 
Event or Problem Description
It was reported that during an angioplasty procedure, the pta balloon was allegedly difficult to retract.It was further reported that the pta balloon detached during retraction.A secondary procedure was done to remove the detached balloon.The procedure was completed using a new balloon.There were no further reported complications.
 
Additional Manufacturer Narrative
Manufacturing review: a manufacturing review was conducted and there was nothing found to indicate there was a manufacturing related cause for this event.Investigation results: the device was returned for evaluation.A visual inspection found that the balloon was detached from the catheter shaft of the device.The balloon was not returned for evaluation.Therefore, the investigation is confirmed for the reported balloon detachment and confirmed for the reported retraction issue.It is likely that the alleged retraction issue contributed to the reported balloon detachment.However, the definite root cause for the reported retraction issue or balloon detachment could not be determined based upon available information.Labeling review: the review of the ifu (instructions for use), indications, warnings, precautions, cautions, possible complications, and contraindications showed that the product labeling is adequate.
 
Event or Problem Description
It was reported that during an angioplasty procedure, the pta balloon was allegedly difficult to retract.It was further reported that the pta balloon detached during retraction.A secondary procedure was done to remove the detached balloon.The procedure was completed using a new balloon.There were no further reported complications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATLAS GOLD PTA DILATATION CATHETER
Common Device Name
PTA BALLOON DILATATION CATHETER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
MDR Report Key8680979
Report Number2020394-2019-00902
Device Sequence Number11280963
Product Code LIT
UDI-Device Identifier00801741060878
UDI-Public(01)00801741060878
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
K181323
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 11/05/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberATG80184
Device Catalogue NumberATG80184
Device Lot Number93ND0080
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/05/2019
Initial Date Received by Manufacturer 05/24/2019
Supplement Date Received by Manufacturer11/04/2019
Initial Report FDA Received Date06/07/2019
Supplement Report FDA Received Date11/05/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age53 YR
-
-